Invenomic Capital Management’s Newmont NEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-194,124
Closed -$11.3M 170
2025
Q2
$11.3M Sell
194,124
-31,407
-14% -$1.68M 0.64% 58
2025
Q1
$10.9M Sell
225,531
-28,739
-11% -$1.26M 0.55% 65
2024
Q4
$9.46M Sell
254,270
-217,429
-46% -$9.91M 0.45% 72
2024
Q3
$25.2M Sell
471,699
-96,049
-17% -$4.77M 1.39% 20
2024
Q2
$23.8M Buy
+567,748
New +$23.2M 1.16% 26

Other funds holding NEM

Invenomic Capital Management's NEM Position: Q3 2025 in Review

Invenomic Capital Management sold out of Newmont (NEM) in Q3 2025, closing a stake of 194,124 shares — an estimated $11.3M sold.

Invenomic Capital Management first reported a position in NEM in Q2 2024 and held it in 5 quarters. The position peaked at $25.2M in Q3 2024. 1,529 funds tracked by Wall St. Rank hold NEM as of Q3 2025.

  • Invenomic Capital Management reported no remaining Newmont position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 194,124 Newmont shares in Q3 2025, an estimated $11.3M.
  • Invenomic Capital Management first reported a position in Newmont in Q2 2024 and held it in 5 quarters.
  • Invenomic Capital Management's Newmont position peaked at $25.2M in Q3 2024.
  • 1,529 funds tracked by Wall St. Rank held Newmont as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.